Five ASX stocks making a buzz today

Summary

  • Frontier Resources has successfully completed its landowner MRA Warden’s hearing as part of the renewal process of its wholly owned tenement.
  • Vection Technologies has achieved a milestone of completing its first public hospital trial of XR solution.
  • Zip co is set to acquire the remaining shares of European BNPL player, Twisto Payments.

Having retreated from the day’s high of 7061.9, the ASX 200 is trading 0.2% up at 7044.7, as of 2:00 PM AEST. Other broader market indices such as ASX 20, ASX 50 and ASX 100 are all trading in green.

Strengthen your Portfolio with Kalkine LITE; Now Available at $19.99 Only

Image Source: Copyright © 2021 Kalkine Media

As far as the market breadth is concerned, 8 out of 11 sectors are trading in green, with the healthcare sector leading the market with 1.4% gain and materials sector losing the most, at 1.18%. Today, individual stocks have witnessed a lot of action and have remained in the spotlight. Let’s have a look at a few of these stocks.

Read More: Five penny stocks flying high today

  1. State Gas Limited (ASX:GAS)

Today, State Gas announced that its first well in its new Rolleston-West Gas Project in Central Queensland has confirmed the existence of gas-bearing coal seams. This strengthens the company’s view that these coals will be developed synergistically with the Reid’s Dome gas discoveries. Gas was observed bubbling from the coal, and field values indicate gas content is likely to be within the expectations.

Image Source: ID 16073862 © Ssuaphoto | Megapixl.com

The GAS share price is trading 1.89% down, at AU$0.52.

Read More: State Gas Limited’s Gas Flow Rates Continue To Increase At Nyada-4

  1. Cynata Therapeutics Limited (ASX:CYP)

Cynata Therapeutics’ share price has increased by 2.5% to AU$0.6 as the company has announced that the first patient has been enrolled in its MEND (MEseNchymal coviD-19) clinical trial. The trial is being conducted to investigate early efficacy of Cynata’s Cymerus™ mesenchymal stem cells (MSCs) in patients with respiratory failure.

Investors seem to be cheerful as the company is progressing with the trial, which is expected to cement Cynata’s world-leading position in the development of next generation commercially scalable stem cell products.

Read More: Cynata Therapeutics Cymerus™ technology to be featured in ISCT presentations

  1. Frontier Resources Limited (ASX:FNT)

Frontier Resources has successfully completed its landowner MRA Warden’s hearing as part of the renewal process of its wholly owned tenement EL2531. Around 40 locals were in attendance and according to the company, the meeting went very well.

Image Source: ID 52427722 © Tomas1111 | Megapixl.com

However, the investors didn’t seem to be satisfied with the update, dragging the FNT share price by 6.2% to AU$0.015.

  1. Vection Technologies Limited (ASX:VR1)

Vection Technologies has achieved a milestone of completing its first public hospital trial of XR solution. The solution enables surgeons to visualise in their field of view (hand-free), in augmented reality (AR), all the data necessary for the surgery, including diagnostic images, surgery checklist, endoscopic video-feed, and more. This is deemed to be a material advancement for the company.

The VR1 share price was trading 5% up at the day’s high. As of 2:00 PM, the stock is trading flat after falling from the high of the day.

Read More: Vection Technologies (ASX:VR1) gains on healthcare & pharma solutions division launch

  1. Zip Co Limited (ASX:Z1P)

BNPL giant Zip Co has agreed to acquire the remaining shares of European BNPL player, Twisto Payments. Additionally, the firm has also entered into an agreement to acquire the remaining shares of UAE-based BNPL leader Spotii Holdings Ltd. The company is going all guns blazing in its quest to become a global giant in this niche space.

Image Source: ID 89303993 © Nitsuki | Megapixl.com

The Z1P share price has faced some profit booking from the day’s high, currently trading 0.71% up at AU$7.08.

Comment


Disclaimer

Ad

GET A FREE STOCK REPORT


Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.


   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK